Skip to main content

Cardiology MCQ 78.

Q. Which of the following is not an absolute contraindication of Sacubitril/valsartan combination?
A. History of hypersensitivity to valsartan
B. History of hyperkalemia with valsartan
C. 1st trimester of pregnancy
D. History of angioedema with ACE inhibitors


Answer: B. History of hyperkalemia with valsartan

Absolute contraindications of sacubitril include

1. History of hypersensitivity to any of component of sacubitril
2. H/o angioedema due to ACE inhibitors or ARBs
3. Pregnancy

Past history of hyperkalemia with valsartan is not a contraindication for the use of sacubitril as such potassium should be normal while starting it. However, potassium level should be monitored more carefully in these patients. Hence, sacubitril can be given to patients who have past history of hyperkalemia due to any cause.

Comments

  1. I read your post and got it quite informative. I couldn't find any knowledge on this matter prior to. I would like to thank you for sharing this article here. Hospital in Montpelier

    ReplyDelete

Post a Comment

Popular posts from this blog

ECG Spotter

What is the diagnosis? Click the button below to view answer: Show Answer

MCQ

 Cardiology MCQ Q. Which of the following leads is not an inferior lead in ECG? A. Lead II B. Lead III C. Lead aVF D. Lead aVR Click the button below to view answer Show answer Correct answer is option D. Lead aVR

Peripartum Cardiomyopathy

Peripartum Cardiomyopathy  (PPCM) •         Usually develops in last month of pregnancy or first 5 months post-delivery. •         Presents as heart failure with reduced ejection fraction (dilated cardiomyopathy) ↳        LV EF < 45%  •         PPCM is a diagnosis of exclusion. •         Risk factors → 1-      History of Hypertension, Pre-eclampsia 2-      Black women •         Incidence → 1 in 2000 live births. •         Management → 1.       Guideline directed medical therapy for HF- Beta-blockers Hydralazine plus isosorbide dinitrate  Diuretics 2.       Bromocriptine 3.       Low threshold for anticoagulation 4. ...